A simple and valid tool distinguished efficacy from effectiveness studies

Journal of Clinical Epidemiology

Volumn 59, Issue 10, 2006, Pages 1040-1048

  Gartlehner, Gerald ^a   Hansen, Richard A ^a   Nissman, Daniel ^b   Lohr, Kathleen N ^c   Carey, Timothy S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

Effectiveness; Efficacy; Explanatory studies; Methods study; Pragmatic studies; Systematic reviews

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CONSTRUCT VALIDITY; EVIDENCE BASED MEDICINE; GOLD STANDARD; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

DRUG THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; REVIEW LITERATURE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 33748550986     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2006.01.011     Document Type: Article

References (57)

1. Rothwell P.M. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 365 (2005) 82-93
2. Godwin M., Ruhland L., Casson I., MacDonald S., Delva D., Birtwhistle R., et al. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med Res Methodol 3 (2003) 28
3. Benson J., and Britten N. Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ 325 (2002) 873
4. Redelmeier D.A., Rozin P., and Kahneman D. Understanding patients' decisions. Cognitive and emotional perspectives. JAMA 270 (1993) 72-76
5. Thomas K.B. General practice consultations: is there any point in being positive?. Br Med J (Clin Res Ed) 294 (1987) 1200-1202
6. Di Blasi Z., Harkness E., Ernst E., Georgiou A., and Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet 357 (2001) 757-762
7. Mulrow C.D. Rationale for systematic reviews. BMJ 309 (1994) 597-599
8. Brook R.H., and Lohr K.N. Efficacy, effectiveness, variations, and quality. Boundary-crossing research. Med Care 23 (1985) 710-722
9. Hoagwood K., Hibbs E., Brent D., and Jensen P. Introduction to the special section: efficacy and effectiveness in studies of child and adolescent psychotherapy. J Consult Clin Psychol 63 (1995) 683-687
10. Schwartz D., and Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 20 (1967) 637-648
11. Califf R.M., and DeMets D.L. Principles from clinical trials relevant to clinical practice: Part I. Circulation 106 (2002) 1015-1021
12. Peto R., Collins R., and Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol 48 (1995) 23-40
13. Harris R.P., Helfand M., Woolf S.H., Lohr K.N., Mulrow C.D., Teutsch S.M., and Atkins D. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20 3 Suppl (2001) 21-35
14. Anonymous. Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews. CRD Report Number 4 (2nd edition) (2001), NHS Centre for Reviews and Dissemination, York, UK
15. Gross C.P., Mallory R., Heiat A., and Krumholz H.M. Reporting the recruitment process in clinical trials: who are these patients and how did they get there?. Ann Intern Med 137 (2002) 10-16
16. Spahn J. Clinical trial efficacy: what does it really tell you?. J Allergy Clin Immunol 112 (2003) S102-S106
17. Fleming T.R., and DeMets D.L. Surrogate end points in clinical trials: are we being misled?. Ann Intern Med 125 (1996) 605-613
18. Coutts J.A., Gibson N.A., and Paton J.Y. Measuring compliance with inhaled medication in asthma. Arch Dis Child 67 (1992) 332-333
19. Gibson N.A., Ferguson A.E., Aitchison T.C., and Paton J.Y. Compliance with inhaled asthma medication in preschool children. Thorax 50 (1995) 1274-1279
20. Kelloway J.S., Wyatt R.A., and Adlis S.A. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 154 (1994) 1349-1352
21. Norman G.R., Sloan J.A., and Wyrwich K.W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41 (2003) 582-592
22. Hollis S., and Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319 (1999) 670-674
23. West S., King V., Carey T.S., Lohr K.N., McKoy N., Sutton S.F., et al. Systems to rate the strength of scientific evidence. Evid Rep Technol Assess (Summ) 47 (2002) 1-11
24. Geldmacher D.S., Provenzano G., McRae T., Mastey V., and Ieni J.R. Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease. J Am Geriatr Soc 51 (2003) 937-944
25. Mendelman P.M., Cordova J., and Cho I. Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults. Vaccine 19 (2001) 2221-2226
26. Jerrell J.M. Cost-effectiveness of risperidone, olanzapine, and conventional antipsychotic medications. Schizophr Bull 28 (2002) 589-605
27. Kroenke K., West S.L., Swindle R., Gilsenan A., Eckert G.J., Dolor R., et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA 286 (2001) 2947-2955
28. Little P., Gould C., Williamson I., Moore M., Warner G., and Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ 322 (2001) 336-342
29. Kawai N., Ikematsu H., Iwaki N., Satoh I., Kawashima T., Maeda T., et al. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season. Clin Infect Dis 40 (2005) 1309-1316
30. Robles N.R., Martin-Agueda B., Lopez-Munoz F., and Alamo C. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients. Int J Clin Pract 59 (2005) 478-484
31. Gane E., Saliba F., Valdecasas G.J., O'Grady J., Pescovitz M.D., Lyman S., et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group. Lancet 350 (1997) 1729-1733
32. Knapp M.J., Knopman D.S., Solomon P.R., Pendlebury W.W., Davis C.S., and Gracon S.I. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. JAMA 271 (1994) 985-991
33. Farlow M., Gracon S.I., Hershey L.A., Lewis K.W., Sadowsky C.H., and Dolan-Ureno J. A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. JAMA 268 (1992) 2523-2529
34. Davis B.R., Cutler J.A., Gordon D.J., Furberg C.D., Wright Jr. J.T., Cushman W.C., et al. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens 9 (1996) 342-360
35. Yusuf S., Mehta S.R., Xie C., Ahmed R.J., Xavier D., Pais P., et al. Effects of Reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. JAMA 293 (2005) 427-435
36. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1 (1986) 397-402
37. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
38. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 345 (2001) 1075-1083
39. Schein O.D., Katz J., Bass E.B., Tielsch J.M., Lubomski L.H., Feldman M.A., et al. The value of routine preoperative medical testing before cataract surgery. Study of Medical Testing for Cataract Surgery. N Engl J Med 342 (2000) 168-175
40. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
41. Jenicek M., and Hitchcock D.L. Evidence-Based Practice. Logic and Critical Thinking in Medicine (2005), AMA Press, USA
42. Bridges C.B., Thompson W.W., Meltzer M.I., Reeve G.R., Talamonti W.J., Cox N.J., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284 (2000) 1655-1663
43. Conley R.R., and Mahmoud R. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder. Am J Psychiatry 158 (2001) 765-774
44. Follath F., Cleland J.G., Just H., Papp J.G., Scholz H., Peuhkurinen K., et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360 (2002) 196-202
45. Klassen T.P., Watters L.K., Feldman M.E., Sutcliffe T., and Rowe P.C. The efficacy of nebulized budesonide in dexamethasone-treated outpatients with croup. Pediatrics 97 (1996) 463-466
46. Maskell N.A., Davies C.W., Nunn A.J., Hedley E.L., Gleeson F.V., Miller R., et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 352 (2005) 865-874
47. McFalls E.O., Ward H.B., Moritz T.E., Goldman S., Krupski W.C., Littooy F., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 (2004) 2795-2804
48. Meltzer H.Y., Alphs L., Green A.I., Altamura A.C., Anand R., Bertoldi A., et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60 (2003) 82-91
49. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 321 (1989) 129-135
50. Plint A.C., Osmond M.H., and Klassen T.P. The efficacy of nebulized racemic epinephrine in children with acute asthma: a randomized, double-blind trial. Acad Emerg Med 7 (2000) 1097-1103
51. Purdon S.E., Jones B.D., Stip E., Labelle A., Addington D., David S.R., et al. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 57 (2000) 249-258
52. Rosenheck R., Cramer J., Allan E., Erdos J., Frisman L.K., Xu W., et al. Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Arch Gen Psychiatry 56 (1999) 565-572
53. Rosenheck R., Perlick D., Bingham S., Liu-Mares W., Collins J., Warren S., et al. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA 290 (2003) 2693-2702
54. Schmid C., Richer M., Bilenge C.M., Josenando T., Chappuis F., Manthelot C.R., et al. Effectiveness of a 10-Day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (Impamel II). J Infect Dis 191 (2005) 1922-1931
55. Stiell I.G., Wells G.A., Field B., Spaite D.W., Nesbitt L.P., De Maio V.J., et al. Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med 351 (2004) 647-656
56. Dennis M.S., Lewis S.C., and Warlow C. Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet 365 (2005) 764-772
57. Wassef A.A., Winkler D.E., Roache A.L., Abobo V.B., Lopez L.M., Averill J.P., et al. Lower effectiveness of divalproex versus valproic acid in a prospective, quasi-experimental clinical trial involving 9,260 psychiatric admissions. Am J Psychiatry 162 (2005) 330-339